Elevated levels of angiogenic cytokines in the plasma of cancer patients

International Journal of Cancer

Volumn 85, Issue 1, 2000, Pages 40-45

  Fuhrmann Benzakein, Edya ^a,b   Ma, Melody N ^a   Rubbia Brandt, Laura ^a   Mentha, Gilles ^b   Ruefenacht, Daniel ^b   Sappino, André Pascal ^b   Pepper, Michael S ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYTOKINE; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SOLID TUMOR;

ADULT; CYTOKINES; ENDOTHELIAL GROWTH FACTORS; FIBROBLAST GROWTH FACTOR 2; HEPATOCYTE GROWTH FACTOR; HUMANS; LYMPHOKINES; MIDDLE AGED; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PROSPECTIVE STUDIES; REFERENCE VALUES; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033991168     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000101)85:1<40::AID-IJC7>3.0.CO;2-L     Document Type: Article

References (21)

1. BRATTSTROM, D., BERGQVIST, M., LARSSON, A., HOLMERTZ, J., HESSELIUS, P., ROSENBERG. L., BRODIN, O. and WAGENIUS, G., Basic fibroblast growth factor and vascular endothelial growth factor in sera from non-small cell lung cancer patients. Anticancer Res., 18, 1123-1127 (1998).
2. CHODAK, G.W., HOSPELHORN, V., JUDGE, S.M., MAYFORTH, R., KOEPPEN, H. and SASSE, J., Increased levels of fibroblast growth factor-like activity in urine from patients with bladder or kidney cancer. Cancer Res., 48, 2083-2088 (1988).
3. DIRIX, L.Y., VERMEULEN, P.B., HUBENS, G., BENOY, I., MARTIN, M., DE POOTER, C. and VAN OOSTEROM, A.T., Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancer. Ann. Oncol., 7, 843-848 (1996).
4. DVORAK, H.F., DETMAR, M., CLAFFEY, K.P., NAGY, J.A., VAN DE WATER, L. and SENGER, D.R., Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int. Arch. Allergy Immunol. 107, 233-235 (1995).
5. FOLKMAN, J., Clinical applications of research on angiogenesis. N. Engl. J. Med., 333, 1757-1763 (1995).
6. GASPARINI, G. and 12 OTHERS, Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. J. nat. Cancer Inst., 89, 139-147 (1997).
7. GUIDI, A.J., ABU-JAWDEH, G., BERSE, B., JACKMAN, R.W., TOGNAZZI, K., DVORAK, H.F. and BROWN, L.F., Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. J. nat. Cancer Inst., 87, 1237-1245 (1995).
8. IVANOVIC, V., MELMAN, A., DAVIS-JOSEPH, B., VALCIC, M. and GELIEBTER, J., Elevated plasma levels of TGF-beta 1 in patients with invasive prostate cancer. Nature (Med.), 1, 282-284 (1995).
9. JOSEPH, A., WEISS, G.H., JIN, L., FUCHS, A., CHOWDHURY, S., GOLDBERG, I.D. and ROSEN, E.M., Expression of scatter factor in human bladder carcinoma. J. nat. Cancer Inst., 87, 372-377 (1995).
10. Li, V.W., FOLKERTH, R.D., WATANABE, H., YU, C., RUPNICK, M., BARNES, P., SCOTT, R.M., BLACK, P.M., SALLAN, S.E. and FOLKMAN, J., Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours. Lancet, 344, 82-86 (1994).
11. MEYER, G.E., YU, E., SIEGAL, J.A., PETTEWAY, J.C., BLUMENSTEIN, B.A. and BRAWER, M.K., Serum basic fibroblast growth factor in men with and without prostate carcinoma. Cancer, 76, 2304-2311 (1995).
12. MOHLE, R., GREEN, D., MOORE, M.A., NACHMAN, R.L. and RAFII, S., Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc. nat. Acad. Sci. (Wash.), 94, 663-668 (1997).
13. NGUYEN, M., WATANABE, H., BUDSON, A.E., RICHIE, J.P., HAYES, D.F. and FOLKMAN, J., Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J. nat. Cancer Inst., 86, 356-361 (1994).
14. PEPPER, M.S., Manipulating angiogenesis. From basic science to the bedside. Arterioscler. Thromb. vasc. Biol., 17, 605-619 (1997).
15. PIERCE, G.F., TARPLEY, J.E., YANAGIHARA, D., MUSTOE, T.A., FOX, G.M. and THOMASON, A., Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair. Amer. J. Pathol., 140, 1375-1388 (1992).
16. SALVEN, P., RUOTSALAINEN, T., MATTSON, K. and JOENSUU, H., High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer. Int. J. Cancer, 79, 144-146 (1998).
17. TAKAHASHI, Y., KITADAI, Y., BUCANA, C.D., CLEARY, K.D. and ELLIS, L.M., Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res., 55, 3964-3968 (1995).
18. TANIGUCHI, T., TOI, M., INARA, K., IMAZAWA, T., YAMAMOTO, Y. and TOMINAGA, T., Serum concentrations of hepatocyte growth factor in breast cancer patients. Clin. Cancer Res., 1, 1031-1034 (1995).
19. TOI, M., TANIGUCHI, T., YAMAMOTO, Y., KURISAKI, T., SUZUKI, H. and TOMINAGA, T., Clinical significance of the determination of angiogenic factors. Europ. J. Cancer, 32A, 2513-2519 (1996).
20. WEBB, N.J., BOTTOMLEY, M.J., WATSON, C.J. and BRENCHLEY, P.E., Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease. Clin. Sci., 94, 395-404 (1998).
21. YAMAMOTO, Y. and 12 OTHERS, Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. Clin. Cancer Res., 2, 821-826 (1996).